| Literature DB >> 32327444 |
Sumanto Haldar1, Leonie Egli2, Carlos Antonio De Castro3, Shia Lyn Tay1, Melvin Xu Nian Koh1, Christian Darimont2, Katherine Mace2, Christiani Jeyakumar Henry4,5.
Abstract
INTRODUCTION: While circadian control of glucose metabolism is well known, how glycemic index (GI) of carbohydrate-rich meals interacts with time of consumption (breakfast or dinner) to influence postprandial (PP) glucose homeostasis is less well established. The objective of the study was to assess markers of PP glucose homeostasis following high or low GI test meals (TM) consumed either at breakfast or at dinner and following consumption of the subsequent standardized meals (SSM). RESEARCH DESIGN AND METHODS: Randomized crossover trial in 34 healthy, Chinese, elderly volunteers (mean±SEM age, 56.8±0.83 years), who completed 4 separate study sessions per-protocol, consisting of a high-GI breakfast, low-GI breakfast, high-GI dinner and low-GI dinner TM, followed by a SSM at the subsequent eating occasion. Blood samples were taken for 3 hours after each TM and SSM for glucose, insulin, glucagon, free fatty acids (FFA) and triglycerides (TG) measurements.Entities:
Keywords: circadian rhythm(s); glycemic control; glycemic index diet; type 2 diabetes
Mesh:
Year: 2020 PMID: 32327444 PMCID: PMC7202752 DOI: 10.1136/bmjdrc-2019-001099
Source DB: PubMed Journal: BMJ Open Diabetes Res Care ISSN: 2052-4897
Figure 1Consolidated Standards of Reporting Trials diagram. A total of 62 volunteers were screened, 48 volunteers enrolled, 37 completed all 4 study sessions and 34 volunteers completed the study as per-protocol. Of the total withdrawn participants, six withdrew from the study before the commencement of study intervention but after informed consent (ie, before session 1), four volunteers withdrew due to their inability to adhere to the study requirements (eg, study food consumption, not able to provide samples or undertake measurements) and one volunteer withdrew for medical reasons. SSM, subsequent standardized meal.
Subjects’ baseline characteristics
| Variable | Level | All subjects enrolled | Per-protocol population |
| N | 48 | 34 | |
| BMI (kg/m2) | 22.1±0.24 | 22.3±0.29 | |
| Height (cm) | 164.1±1.11 | 165.7±1.35 | |
| Weight (kg) | 59.7±1.24 | 61.6±1.57 | |
| Waist circumference (cm) | 76.2±1.11 | 77.8±1.39 | |
| Hip circumference (cm) | 94.0±0.77 | 94.7±0.79 | |
| SBP (mm Hg) | 124.5±1.76 | 122.6±2.09 | |
| DBP (mm Hg) | 78.3±1.11 | 78.7±1.40 | |
| Fasting glucose (mmol/L) | 4.6±0.07 | 4.6±0.10 | |
| Heart rate (bpm) | 61.7±1.47 | 62.2±2.00 | |
| Age (years) | 56.9±0.71 | 56.8±0.83 | |
| Gender | Female | 22 | 13 |
| Male | 26 | 21 | |
| Smoker | No | 48 | 34 |
| Alcohol consumption | No | 40 | 28 |
| Yes | 8 | 6 |
Data are expressed as mean±SEM; gender, smoker and alcohol consumption are expressed as number of subjects.
BMI, body mass index; DBP, diastolic blood pressure; N, number of subjects; SBP, systolic blood pressure.
Figure 2Postprandial substrate and hormone concentrations following test meals (TM) and subsequent standard meals (SSM) for up to 3-hour measurement periods after each meal. Mean±SEM concentrations of serum glucose (A), serum insulin (B), serum triglycerides (TG) (C), plasma free fatty acids (FFA) (D) and plasma glucagon (E) after high-glycemic index breakfast (Hi-Br), low-glycemic index breakfast (Lo-Br), high-glycemic index dinner (Hi-Di), low-glycemic index dinner (Lo-Di) TM and SSM. For all variables, n=34 subjects, except for FFA, n=29.
Test meal (TM) and subsequent standard meal (SSM) incremental areas under the curve (iAUCs) of postprandial responses for various substrates and hormones
| Variable | MT | GI | N | TM | SSM | ||||||||
| Mean | SD | Comparison | Contrast | P value† | Mean | SD | Comparison | Contrast | P value† | ||||
| Glucose | BR | Hi | 34 | 481.99 | 192.50 | Hi vs Lo (overall) | 142.01 | 140.70 | 155.36 | Hi vs Lo (overall) | 70.96 | ||
| Lo | 34 | 378.64 | 158.75 | Di vs Br (overall) | 245.75 | 93.83 | 156.48 | Di vs Br (overall) | 155.78 | ||||
| DI | Hi | 34 | 766.40 | 320.61 | Br: Hi vs Lo | 103.35 | 320.57 | 151.72 | Br: Hi vs Lo | 46.87 | 0.1836 | ||
| Lo | 34 | 585.74 | 215.50 | Di: Hi vs Lo | 180.66 | 225.52 | 108.36 | Di: Hi vs Lo | 95.05 | ||||
| Hi: Di vs Br | 284.40 | Hi: Di vs Br | 179.88 | ||||||||||
| Lo: Di vs Br | 207.10 | Lo: Di vs Br | 131.69 | ||||||||||
| Insulin | BR | Hi | 34 | 5643.62 | 3093.41 | Hi vs Lo (overall) | 2729.25 | 2447.71 | 1651.66 | Hi vs Lo (overall) | −232.46 | 0.4477 | |
| Lo | 34 | 3269.08 | 2073.61 | Di vs Br (overall) | 865.96 | 3454.72 | 2338.81 | Di vs Br (overall) | 2462.41 | ||||
| DI | Hi | 34 | 6864.29 | 3714.81 | Br: Hi vs Lo | 2374.54 | 5684.67 | 3420.26 | |||||
| Lo | 34 | 3692.37 | 2039.35 | Di: Hi vs Lo | 3083.97 | 5141.35 | 2288.56 | ||||||
| Hi: Di vs Br | 1220.67 | ||||||||||||
| Lo: Di vs Br | 511.24 | 0.3481 | |||||||||||
| Triglycerides | BR | Hi | 34 | 3.98 | 7.93 | Hi vs Lo (overall) | 0.77 | 0.7772 | 53.62 | 27.28 | Hi vs Lo (overall) | 7.21 | |
| Lo | 34 | 2.58 | 3.60 | Di vs Br (overall) | 9.66 | 42.93 | 21.43 | Di vs Br (overall) | −13.42 | ||||
| DI | Hi | 34 | 13.02 | 18.47 | Br: Hi vs Lo | 1.40 | 0.7465 | 36.72 | 36.57 | Br: Hi vs Lo | 10.69 | ||
| Lo | 34 | 12.87 | 18.88 | Di: Hi vs Lo | 0.15 | 0.9645 | 32.99 | 30.08 | Di: Hi vs Lo | 3.73 | 0.4473 | ||
| Hi: Di vs Br | 9.04 | Hi: Di vs Br | −16.90 | ||||||||||
| Lo: Di vs Br | 10.29 | Lo: Di vs Br | −9.94 | ||||||||||
| Free fatty acids | BR | Hi | 29 | −59504.89 | 26 273.50 | Hi vs Lo (overall) | −3703.86 | 0.3504 | 496.98 | 7870.64 | Hi vs Lo (overall) | −3967.37 | 0.1552 |
| Lo | 30 | −50405.09 | 18 057.99 | Di vs Br (overall) | 8766.81 | −3446.39 | 7360.76 | Di vs Br (overall) | −56096.50 | ||||
| DI | Hi | 29 | −45272.73 | 22 182.40 | Br: Hi vs Lo | −8909.32 | 0.1022 | −63524.99 | 24 943.72 | ||||
| Lo | 29 | −46774.32 | 26 604.49 | Di: Hi vs Lo | 1501.59 | 0.7772 | −51358.61 | 17 701.28 | |||||
| Hi: Di vs Br | 13 972.27 | ||||||||||||
| Lo: Di vs Br | 3561.36 | 0.5193 | |||||||||||
| Glucagon | BR | Hi | 34 | −637.76 | 354.44 | Hi vs Lo (overall) | −118.79 | 0.1233 | 647.97 | 374.81 | Hi vs Lo (overall) | 111.58 | |
| Lo | 34 | −564.90 | 333.75 | Di vs Br (overall) | −126.52 | 0.1022 | 317.80 | 293.40 | Di vs Br (overall) | −435.34 | |||
| DI | Hi | 34 | −820.98 | 502.17 | Br: Hi vs Lo | −93.00 | 0.3889 | −48.14 | 395.24 | ||||
| Lo | 34 | −671.83 | 589.98 | Di: Hi vs Lo | −144.58 | 0.1878 | 77.36 | 447.54 | |||||
| Hi: Di vs Br | −152.31 | 0.1653 | |||||||||||
| Lo: Di vs Br | −100.73 | 0.3619 | |||||||||||
Linear mixed models were used to compare the iAUCs following TM according to the GI and MT in a 2×2 analyses. Significance was set at p<0.05.
‘Hi vs Lo overall’—when dinner and breakfast combined. ‘Di vs Br overall’—when high and low GI combined.
Bold values are statistically significant.
*Adjustments for multiplicity was done using the False Discovery Rate method.
†Only when GI:MT interaction significant, subgroup analyses are shown in italics.
BR, breakfast; DI, dinner; GI, glycemic index; Hi, high GI; Lo, low GI; MT, meal time; N, number.
Combined total areas under the curves (tAUCs) of test meals (TM) and subsequent standard meal (SSM) postprandial responses for various substrates and hormones
| Variable | Meal time | GI | N | Mean | SD | Comparison | Contrast | P value† |
| Glucose | BR | Hi | 34 | 2493.32 | 334.44 | Hi vs Lo (overall) | 181.11 | |
| Lo | 34 | 2423.70 | 328.43 | Di vs Br (overall) | 296.81 | |||
| DI | Hi | 34 | 2901.62 | 442.64 | ||||
| Lo | 34 | 2609.02 | 306.35 | |||||
| Insulin | BR | Hi | 34 | 11 425.73 | 6261.91 | Hi vs Lo (overall) | 2686.65 | |
| Lo | 34 | 9516.74 | 4963.53 | Di vs Br (overall) | 1572.55 | |||
| DI | Hi | 34 | 13 775.94 | 6962.72 | Br: Hi vs Lo | 1908.99 | ||
| Lo | 34 | 10 126.83 | 4127.53 | Di: Hi vs Lo | 3464.31 | |||
| Hi: Di vs Br | 2350.21 | |||||||
| Lo: Di vs Br | 794.89 | 0.3125 | ||||||
| Triglycerides | BR | Hi | 34 | 421.39 | 156.72 | Hi vs Lo (overall) | −3.30 | 0.9097 |
| Lo | 34 | 395.60 | 155.64 | Di vs Br (overall) | 158.25 | |||
| DI | Hi | 34 | 550.54 | 278.76 | Br: Hi vs Lo | 25.79 | 0.5690 | |
| Lo | 34 | 582.93 | 404.90 | Di: Hi vs Lo | −32.39 | 0.4981 | ||
| Hi: Di vs Br | 129.16 | |||||||
| Lo: Di vs Br | 187.33 | |||||||
| Free fatty acids | BR | Hi | 29 | 44 669.53 | 14 708.28 | Hi vs Lo (overall) | −2131.99 | 0.4862 |
| Lo | 30 | 50 423.81 | 17 067.00 | Di vs Br (overall) | 36 217.11 | |||
| DI | Hi | 29 | 84 738.51 | 17 216.24 | Br: Hi vs Lo | −5761.22 | 0.1680 | |
| Lo | 29 | 83 241.27 | 18 907.22 | Di: Hi vs Lo | 1497.24 | 0.7035 | ||
| Hi: Di vs Br | 39 846.33 | |||||||
| Lo: Di vs Br | 32 587.88 | |||||||
| Glucagon | BR | Hi | 34 | 1601.86 | 560.85 | Hi vs Lo (overall) | −81.57 | 0.1906 |
| Lo | 34 | 1563.72 | 570.10 | Di vs Br (overall) | 207.56 | |||
| DI | Hi | 34 | 1638.99 | 659.15 | ||||
| Lo | 34 | 1885.22 | 766.10 | |||||
Linear mixed models were used to compare the combined tAUCs following TM+SSM according to the GI and MT in a 2×2 analyses. Significance was set at p<0.05.
‘Hi vs Lo overall’—when dinner and breakfast combined. ‘Di vs Br overall’—when high and low GI combined.
Bold values are statistically significant.
*Only when GI:MT interaction significant, subgroup analyses are shown in italics.
†Adjustments for multiplicity was done using the False Discovery Rate method.
BR, breakfast; DI, dinner; GI, glycemic index; Hi, high GI; Lo, low GI; MT, meal time; N, number.